In the present study we have evaluated changes in nerve growth factor (NGF), brain-derived neurotrophic factor, and neurotrophin 3 (NT-3) mRNA expression induced by different glutamate receptor agonists injected into the neostriatum. Up-regulation of NGF expression was observed at 24 h after intrastriatal quinolinate injection, an N-methyl-D-aspartate receptor agonist, and this increase was maintained up to 7 days after lesion. NGF up-regulation was also apparent in ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) treatment from 6 to 16 h postinjection. Instead, BDNF was up-regulated only at 6 h after kainate or AMPA excitotoxicity. Interestingly, NT-3 mRNA was down-regulated from 10 to 16 h following AMPA lesion, while 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid injection enhanced NT-3 mRNA levels at 10 h. Our results show a specific neurotrophin response induced by stimulation of each glutamate receptor. These activity-dependent changes might be involved in neuronal plasticity processes and may underlie the differential vulnerability of striatal neurons observed in neurodegenerative disorders.
INTRODUCTION
The ability of neurotrophic factors to regulate neuronal survival during development and adult nervous system plasticity suggests the use of these molecules for treatment of neurodegeneration associated with human disorders (for review see Connor & Dragunow, 1998; Hefti, 1994) . The basal ganglia are affected in several neurodegenerative diseases such as Huntington's chorea and Parkinson's disease. Several authors reported that neurotrophins and other trophic factors can be good candidates for therapy of Huntington's disease, as these factors have protective effects on different striatal neuronal populations (Emerich et al., 1997; Mizuno et al., 1994; Pérez-Navarro et al., 1996; Ventimiglia et al., 1995) .
The expression of nerve growth factor (NGF) (Altar, 1991; Mobley et al., 1989 ), brain-derived neurotrophic factor (BDNF) (Timmusk et al., 1994) , and neurotrophin-3 (NT-3) (Hohn et al., 1990) has been consistently demonstrated in the neostriatum. In fact, it has been reported that several populations of striatal neurons are rescued by neurotrophins from excitotoxicity. NGF is known to prevent the degeneration of both cholinergic interneurons and projection neurons (Davies & Beardsall, 1992; Emerich et al., 1994; Frim et al., 1993; Kordower et al., 1994; Martínez-Serrano & Bjö rklund, 1996; Pérez-Navarro et al., 1994; Pérez-Navarro & Alberch, 1995; Venero et al., 1994) . BDNF promotes the phenotypic differentiation and survival of striatal GABAergic neurons against excitotoxicity in vitro (Mizuno et al., 1994; Ventimiglia et al., 1995) and in
